Deutsche Bank defends Eli Lilly (LLY) on Novo-related sell-off
Tweet Send to a Friend
Deutsche Bank analyst James Shin reiterated a Buy rating and $1,010.00 price target on Eli Lilly (NYSE: LLY), telling clients ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


